ADRB3 and peripheral arterial disease: More recently, we showed that administration of CL316,243, a specific β3AR agonist, stimulated human umbilical vein EC migration and tubule formation in a NOS-dependent manner in vitro, and crucially, CL316,243 improved blood perfusion and angiogenesis in a mouse model of diabetic PAD (98).